Pharmacogenomics: Podcast interview with Medco's Felix Frueh

Medco Health Solutions and the American Medical Association sponsored a survey of 10,000 physicians in the US regarding pharmacogenomics (PGx). Almost all physicians think genetics play an important role in how patients respond to a drug, yet only 13 percent had ordered these tests for their patients. Better informed physicians were more likely to order the tests than others.

In this podcast interview with Felix Frueh, vice president of personalized medicine research and development at Medco, we discuss the varying definitions of PGx, how the tests are being used today and how that’s likely to change over time, and the role Medco and its competitors are playing.

Survey results are available online.

November 16, 2009

2 thoughts on “Pharmacogenomics: Podcast interview with Medco's Felix Frueh”

Leave a Reply

Your email address will not be published. Required fields are marked *